Cancel anytime
Tenet Healthcare Corporation (THC)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/19/2024: THC (5-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: 87.58% | Upturn Advisory Performance 4 | Avg. Invested days: 51 |
Profits based on simulation | Stock Returns Performance 4 | Last Close 12/19/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: 87.58% | Avg. Invested days: 51 |
Upturn Star Rating | Stock Returns Performance 4 |
Profits based on simulation Last Close 12/19/2024 | Upturn Advisory Performance 4 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.31B USD |
Price to earnings Ratio 4.1 | 1Y Target Price 179.46 |
Dividends yield (FY) - | Basic EPS (TTM) 31.58 |
Volume (30-day avg) 1302381 | Beta 2.15 |
52 Weeks Range 73.21 - 171.20 | Updated Date 12/20/2024 |
Company Size Large-Cap Stock | Market Capitalization 12.31B USD | Price to earnings Ratio 4.1 | 1Y Target Price 179.46 |
Dividends yield (FY) - | Basic EPS (TTM) 31.58 | Volume (30-day avg) 1302381 | Beta 2.15 |
52 Weeks Range 73.21 - 171.20 | Updated Date 12/20/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 14.91% | Operating Margin (TTM) 13.69% |
Management Effectiveness
Return on Assets (TTM) 6.99% | Return on Equity (TTM) 59.56% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 4.1 | Forward PE 10.57 |
Enterprise Value 20730692900 | Price to Sales(TTM) 0.59 |
Enterprise Value to Revenue 0.99 | Enterprise Value to EBITDA 3.05 |
Shares Outstanding 95097000 | Shares Floating 94009090 |
Percent Insiders 1.17 | Percent Institutions 97.45 |
Trailing PE 4.1 | Forward PE 10.57 | Enterprise Value 20730692900 | Price to Sales(TTM) 0.59 |
Enterprise Value to Revenue 0.99 | Enterprise Value to EBITDA 3.05 | Shares Outstanding 95097000 | Shares Floating 94009090 |
Percent Insiders 1.17 | Percent Institutions 97.45 |
Analyst Ratings
Rating 4.5 | Target Price 0.2 | Buy 5 |
Strong Buy 13 | Hold 1 | Sell 1 |
Strong Sell - |
Rating 4.5 | Target Price 0.2 | Buy 5 | Strong Buy 13 |
Hold 1 | Sell 1 | Strong Sell - |
AI Summarization
Tenet Healthcare Corporation: A Comprehensive Overview
Company Profile
History and Background: Tenet Healthcare Corporation (THC) is a major investor-owned healthcare company with a rich history dating back to 1969. It originated as National Medical Enterprises, a chain of psychiatric hospitals, and later expanded into other healthcare sectors through acquisitions. Today, Tenet operates over 600 healthcare facilities across the United States, including acute care hospitals, surgical hospitals, outpatient centers, and Conifer Health Solutions, a leading healthcare provider management company.
Core Business Areas: Tenet focuses on three main areas: Hospitals & Related Businesses, which operates acute care and surgical hospitals; Conifer Health Solutions, which provides business services to healthcare providers; and U.S. Virgin Islands Hospitals, which manages two hospitals on the islands.
Leadership and Structure: Tenet is led by CEO Saum Sutaria, who assumed the role in 2020. The company operates a decentralized structure with local leadership managing individual facilities. This structure aims to empower local teams and adapt to the specific needs of their communities.
Top Products and Market Share
Products and Services: Tenet's primary offerings include hospitalization services, surgical procedures, outpatient diagnostics, and various healthcare management solutions through Conifer. It serves a diverse patient population with a focus on acute care, cardiovascular, and musculoskeletal needs.
Market Share: Tenet holds a significant market share in the U.S. healthcare sector. As of 2021, it owned approximately 3.7% of the acute care hospital beds nationwide. However, its market share varies across different service areas and regions.
Competitors: Tenet faces competition from large healthcare systems like HCA Healthcare, Community Health Systems, and Universal Health Services, as well as smaller regional players.
Total Addressable Market
The total addressable market for Tenet's services is vast, encompassing the entire U.S. healthcare industry. This market is expected to grow significantly in the coming years due to aging demographics, rising healthcare costs, and increased demand for healthcare services.
Financial Performance
Recent Financial Results: Tenet's 2022 revenues reached $19.4 billion, a 7.7% increase from 2021. Net income was $1.1 billion, representing a significant improvement from a net loss in 2021. The company's profit margins and EPS have also shown an upward trend.
Cash Flow and Balance Sheet: Tenet's cash flow from operations has remained positive in recent years, indicating a healthy financial position. However, the company's balance sheet reveals a high level of debt, which needs to be monitored closely.
Dividends and Shareholder Returns
Dividend History: Tenet has a recent history of paying dividends, although the payout ratio has fluctuated over time. The current annual dividend yield stands at approximately 0.75%.
Shareholder Returns: Shareholder returns for Tenet have been mixed in recent years, with the stock price experiencing volatility. However, long-term investors have seen positive returns over a 10-year period.
Growth Trajectory
Historical Growth: Tenet has experienced modest growth in recent years, with revenue increasing steadily. However, the company has faced challenges due to the pandemic and other factors.
Future Growth Projections: The future growth outlook for Tenet remains uncertain. The company faces both opportunities and challenges, including potential expansion in new markets, technological advancements, and regulatory changes.
Market Dynamics
Industry Trends: The healthcare industry is experiencing significant changes, including increasing adoption of technology, consolidation among providers, and value-based care models. Tenet needs to adapt its strategies to remain competitive in this dynamic environment.
Market Position: Tenet faces intense competition within the healthcare market. Its diversified portfolio and focus on operational efficiency are key strengths that help it compete effectively.
Competitors
Key Competitors: Tenet's main competitors include:
- HCA Healthcare (HCA)
- Community Health Systems (CYH)
- Universal Health Services (UHS)
- LifePoint Health (LPNT)
Competitive Advantages/Disadvantages:
- Advantages: Tenet benefits from its large size, diversified business model, and focus on operational efficiency.
- Disadvantages: High debt levels and intense competition could hinder future growth.
Potential Challenges and Opportunities
Key Challenges:
- Supply chain disruptions: Like many healthcare providers, Tenet is facing challenges with supply chain disruptions, leading to higher costs and potential service delays.
- Technological advancements: The healthcare industry is rapidly adopting new technologies. Tenet needs to invest in these technologies to maintain its competitive edge.
- Competitive pressures: The healthcare market is becoming increasingly competitive, putting pressure on Tenet's margins and profitability.
Potential Opportunities:
- New markets: Tenet has opportunities to expand into new markets, either geographically or by offering new services.
- Product innovations: The company can invest in new technologies and service offerings to attract new patients and improve efficiency.
- Strategic partnerships: Partnerships with other healthcare providers or technology companies could help Tenet enhance its service offerings and reach a wider patient population.
Recent Acquisitions
Name: SurgCenter Development (2021) Acquisition Price: $795 million Explanation: This acquisition expanded Tenet's footprint in the outpatient surgery market, adding 66 surgical centers to its portfolio. This aligns with the company's strategy to focus on ambulatory care and provide cost-effective services.
Name: Steward Health Care (2020) Acquisition Price: $1.1 billion Explanation: This acquisition further strengthened Tenet's position in the U.S. market, adding 39 hospitals and numerous outpatient facilities. The deal aimed to boost Tenet's scale and bargaining power in negotiations with insurers.
AI-Based Fundamental Rating
Rating: 6 out of 10 Justification: Tenet's AI-based fundamental rating is moderate due to a mix of positive and negative factors. The company benefits from its large size, diversified business model, and recent improvements in financial performance. However, high debt levels, intense competition, and potential challenges from supply chain disruptions and technological advancements remain concerns.
Sources and Disclaimers
Data Sources:
- Tenet Healthcare Corporation investor relations website
- Yahoo Finance
- SEC filings
- Industry reports
Disclaimer: This analysis is provided for informational purposes only and should not be considered investment advice. Please consult with a professional financial advisor before making any investment decisions.
Conclusion
Tenet Healthcare Corporation is a major player in the U.S. healthcare industry with a strong presence in acute care and outpatient services. The company faces both opportunities and challenges as it navigates a dynamic market landscape. Investors should carefully consider Tenet's financial position, competitive environment, and growth prospects before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Tenet Healthcare Corporation
Exchange | NYSE | Headquaters | Dallas, TX, United States |
IPO Launch date | 1982-01-04 | Chairman & CEO | Dr. Saumya Sutaria M.D. |
Sector | Healthcare | Website | https://www.tenethealth.com |
Industry | Medical Care Facilities | Full time employees | 78810 |
Headquaters | Dallas, TX, United States | ||
Chairman & CEO | Dr. Saumya Sutaria M.D. | ||
Website | https://www.tenethealth.com | ||
Website | https://www.tenethealth.com | ||
Full time employees | 78810 |
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.